| Income Statement |
| Operating Expenses | 18.94M |
|
| Research and Development Expense | 12.52M |
| Selling, General and Administrative Expense | 6.42M |
| Operating Income | -18.94M |
| Income Tax Expense | 16.00K |
| Net Income | -17.81M |
| Net Income Common Stock | -17.81M |
| Net Income Common Stock (USD) | -17.81M |
| Consolidated Income | -17.81M |
| Earnings per Basic Share | -0.26 |
| Earnings per Basic Share (USD) | -0.26 |
| Earnings per Diluted Share | -0.26 |
| Earning Before Interest & Taxes (EBIT) | -17.80M |
| Earning Before Interest & Taxes (USD) | -17.80M |
| Weighted Average Shares | 69.20M |
| Weighted Average Shares Diluted | 69.20M |
| Balance Sheet |
| Cash and Equivalents | 24.31M |
| Cash and Equivalents (USD) | 24.31M |
| Investments | 94.47M |
| Investments Current | 94.47M |
| Current Assets | 120.33M |
| Property, Plant & Equipment Net | 19.26M |
| Total Assets | 141.40M |
| Debt Current | 3.23M |
| Total Debt | 16.09M |
| Current Liabilities | 9.01M |
| Debt Non-Current | 12.86M |
| Total Liabilities | 21.86M |
| Accumulated Retained Earnings (Deficit) | -396.69M |
| Accumulated Other Comprehensive Income | -117.00K |
| Shareholders Equity | 119.53M |
| Shareholders Equity (USD) | 119.53M |
| Assets Non-Current | 21.07M |
| Total Debt (USD) | 16.09M |
| Liabilities Non-Current | 12.86M |
| Trade and Non-Trade Payables | 1.10M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 253.00K |
| Net Cash Flow from Financing | -65.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.39M |
| Capital Expenditure | -30.00K |
| Issuance (Purchase) of Equity Shares | 110.00K |
| Net Cash Flow from Investing | -3.52M |
| Net Cash Flow - Investment Acquisitions and Disposals | -3.49M |
| Net Cash Flow from Operations | -15.81M |
| Effect of Exchange Rate Changes on Cash | 1000 |
| Share Based Compensation | 3.31M |